Jeff Auxier's MRK Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 117,346 shares of Merck & Co., Inc. (MRK) worth $12.35 M, representing 1.74% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in MRK, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2015, adding 12,486 shares. Largest reduction occurred in Q4 2018, reducing 22,086 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Merck & Co (MRK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Merck & Co (MRK) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1,218 | Reduce 1.03% | 117,346 | $105.26 |
| Q3 2025 | -447 | Reduce 0.38% | 118,564 | $83.93 |
| Q2 2025 | -368 | Reduce 0.31% | 119,011 | $79.16 |
| Q1 2025 | +238 | Add 0.20% | 119,379 | $89.76 |
| Q4 2024 | -1,290 | Reduce 1.07% | 119,141 | $99.48 |
| Q3 2024 | -65 | Reduce 0.05% | 120,431 | $113.56 |
| Q2 2024 | -101 | Reduce 0.08% | 120,496 | $123.80 |
| Q1 2024 | -2,198 | Reduce 1.79% | 120,597 | $131.95 |
| Q4 2023 | -1,336 | Reduce 1.08% | 122,795 | $109.02 |
| Q3 2023 | +98 | Add 0.08% | 124,131 | $102.95 |
| Q2 2023 | +1,131 | Add 0.92% | 124,033 | $115.39 |
| Q1 2023 | -2,955 | Reduce 2.35% | 122,902 | $106.39 |
| Q4 2022 | -60 | Reduce 0.05% | 125,857 | $110.95 |
| Q3 2022 | -152 | Reduce 0.12% | 125,917 | $86.12 |
| Q2 2022 | -1,510 | Reduce 1.18% | 126,069 | $91.17 |
| Q1 2022 | -3,012 | Reduce 2.31% | 127,579 | $82.05 |
| Q4 2021 | -201 | Reduce 0.15% | 130,591 | $76.64 |
| Q3 2021 | -184 | Reduce 0.14% | 130,792 | $75.11 |
| Q2 2021 | -5,396 | Reduce 3.96% | 130,976 | $77.77 |
| Q1 2021 | +3,139 | Add 2.36% | 136,372 | $73.56 |
| Q4 2020 | +880 | Add 0.66% | 133,233 | $78.05 |
| Q3 2020 | -21 | Reduce 0.02% | 132,353 | $79.15 |
| Q2 2020 | -1,284 | Reduce 0.96% | 132,374 | $73.79 |
| Q1 2020 | -367 | Reduce 0.27% | 133,658 | $73.42 |
| Q4 2019 | -267 | Reduce 0.20% | 134,025 | $86.78 |
| Q3 2019 | +168 | Add 0.13% | 134,292 | $80.32 |
| Q2 2019 | -2,070 | Reduce 1.52% | 134,124 | $80.01 |
| Q1 2019 | -2,201 | Reduce 1.59% | 136,194 | $79.36 |
| Q4 2018 | -22,086 | Reduce 13.76% | 138,395 | $72.91 |
| Q3 2018 | -419 | Reduce 0.26% | 160,481 | $67.69 |
| Q2 2018 | -6,812 | Reduce 4.06% | 160,900 | $57.92 |
| Q1 2018 | -495 | Reduce 0.29% | 167,712 | $51.98 |
| Q4 2017 | +7,179 | Add 4.46% | 168,207 | $53.70 |
| Q3 2017 | +4,653 | Add 2.98% | 161,028 | $61.09 |
| Q2 2017 | +63 | Add 0.04% | 156,375 | $61.15 |
| Q1 2017 | -4,507 | Reduce 2.80% | 156,312 | $60.63 |
| Q4 2016 | +315 | Add 0.20% | 160,819 | $56.17 |
| Q3 2016 | -158 | Reduce 0.10% | 160,504 | $59.55 |
| Q1 2016 | -104 | Reduce 0.06% | 160,662 | $50.48 |
| Q4 2015 | +12,486 | Add 8.42% | 160,766 | $50.40 |
| Q3 2015 | -3,820 | Reduce 2.51% | 148,280 | $47.13 |
| Q2 2015 | -210 | Reduce 0.14% | 152,100 | $54.32 |
| Q1 2015 | -2,096 | Reduce 1.36% | 152,310 | $54.85 |
| Q4 2014 | -157 | Reduce 0.10% | 154,406 | $54.19 |
| Q3 2014 | -2,358 | Reduce 1.50% | 154,563 | $56.57 |
| Q2 2014 | -15,160 | Reduce 8.81% | 156,921 | $55.20 |
| Q1 2014 | -6,969 | Reduce 3.89% | 172,081 | $54.17 |
| Q4 2013 | -209 | Reduce 0.12% | 179,050 | $47.76 |
| Q3 2013 | -105 | Reduce 0.06% | 179,259 | $45.43 |
| Q2 2013 | +179,365 | Add 0.00% | 179,364 | $44.32 |
Jeff Auxier's Merck & Co Investment FAQs
Jeff Auxier first purchased Merck & Co., Inc. (MRK) in Q2 2013, acquiring 179,364 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Merck & Co., Inc. (MRK) for 51 quarters since Q2 2013.
Jeff Auxier's largest addition to Merck & Co., Inc. (MRK) was in Q2 2013, adding 179,364 shares worth $7.95 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 117,346 shares of Merck & Co., Inc. (MRK), valued at approximately $12.35 M.
As of the Q4 2025 filing, Merck & Co., Inc. (MRK) represents approximately 1.74% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Merck & Co., Inc. (MRK) was 179,364 shares, as reported at the end of Q2 2013.